Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Lanreotide Acetate Extended Release Inj 120 Mg/0.5ml (CDM Rx69097087067) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 11, 2026 , from http://ppman.hank.ai/transparency/procedure/Rx69097087067/by-state?code_type=CDM
“Lanreotide Acetate Extended Release Inj 120 Mg/0.5ml (CDM Rx69097087067) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/Rx69097087067/by-state?code_type=CDM. Accessed
October 11, 2026 .
“Lanreotide Acetate Extended Release Inj 120 Mg/0.5ml (CDM Rx69097087067) by State,” HANK Price Transparency ,
accessed October 11, 2026 ,
http://ppman.hank.ai/transparency/procedure/Rx69097087067/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
Rx69097087067 — Lanreotide Acetate Extended Release Inj 120 Mg/0.5ml
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$15,581
National median
$14,802 – $15,581
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for Rx69097087067 (CDM), with interquartile range
State Median p25 p75
WA $15,581 $14,802 $15,581